Followers | 3 |
Posts | 16 |
Boards Moderated | 0 |
Alias Born | 01/31/2024 |

Thursday, June 19, 2025 5:42:04 AM
Yes, LWLG is expanding into Asia — and that’s likely part of a broader strategy to establish sales infrastructure, support foundry integrations, and explore pilot opportunities with smaller players. It looks good on paper and, if genuine, could eventually lead to something. But it may just as well be designed to maintain investor confidence while actual adoption remains years away. We don’t know who they’re talking to.
A basher would say they’re just going there to mislead investors and buy time.
A believer would say they’re exploring opportunities with smaller companies (Tier 2/3)
A bullshitter would claim they were there negotiating with a Tier 1.
Overhyping now only increases the risk of disappointment when the “breakthrough” still hasn’t arrived by next year.
Recent LWLG News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:41:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:39:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/02/2025 08:32:46 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/20/2025 08:54:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2025 08:17:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/16/2025 08:11:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 09:02:04 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 04/30/2025 08:05:23 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2025 09:10:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/28/2025 09:19:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/21/2025 09:11:35 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/21/2025 09:08:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/18/2025 09:03:04 PM
- Lightwave Logic to Host Annual Meeting of Shareholders on May 15, 2025 • PR Newswire (US) • 03/17/2025 12:30:00 PM
- Lightwave Logic to Attend the 37th Annual ROTH Conference • PR Newswire (US) • 03/11/2025 12:30:00 PM
- Lightwave Logic and Polariton Technologies Expand Technical Partnership to Accelerate Introduction of 400Gb/s per lane and beyond for AI and Datacenter Optical Links • PR Newswire (US) • 03/10/2025 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2025 10:41:24 PM
- Lightwave Logic to Host Special Call on March 13, 2025 • PR Newswire (US) • 03/03/2025 09:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2025 07:47:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 09:06:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 09:37:05 PM
- Lightwave Logic to Attend the 2025 SPIE Photonics West Conference • PR Newswire (US) • 01/27/2025 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2025 09:04:19 PM
- Lightwave Logic Director Frederick Leonberger to Retire from Board of Directors and Transition to Company's Advisory Board • PR Newswire (US) • 01/03/2025 01:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2025 10:02:39 PM
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • BLEG • Jul 14, 2025 1:23 PM
VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM